These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 1845568)
1. Mechanisms of reinforcement and their relation to future developments in pharmacotherapy. Dworkin SI; Smith JE Alcohol Alcohol Suppl; 1991; 1():39-47. PubMed ID: 1845568 [TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders. Brady KT; Verduin ML Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091 [TBL] [Abstract][Full Text] [Related]
3. [Dynamic paradigm in psychopathology: "chaos theory", from physics to psychiatry]. Pezard L; Nandrino JL Encephale; 2001; 27(3):260-8. PubMed ID: 11488256 [TBL] [Abstract][Full Text] [Related]
4. The pathophysiologies of substance abuse and affective disorders: an integrative model? Dilsaver SC J Clin Psychopharmacol; 1987 Feb; 7(1):1-10. PubMed ID: 3546402 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of co-occurring affective disorders and substance use disorders. Myrick H; Cluver J; Swavely S; Peters H Psychiatr Clin North Am; 2004 Dec; 27(4):649-59. PubMed ID: 15550285 [TBL] [Abstract][Full Text] [Related]
6. Adult neurogenesis: from precursors to network and physiology. Abrous DN; Koehl M; Le Moal M Physiol Rev; 2005 Apr; 85(2):523-69. PubMed ID: 15788705 [TBL] [Abstract][Full Text] [Related]
7. [Behavioral and neuropharmacologic mechanisms regulating the ingestion of alcohol]. De Witte P Acta Psychiatr Belg; 1985; 85():676-88. PubMed ID: 2869647 [TBL] [Abstract][Full Text] [Related]
8. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders]. Liraud F; Verdoux H Encephale; 2002; 28(2):160-8. PubMed ID: 11972143 [TBL] [Abstract][Full Text] [Related]
12. Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Roth ME; Cosgrove KP; Carroll ME Neurosci Biobehav Rev; 2004 Oct; 28(6):533-46. PubMed ID: 15527861 [TBL] [Abstract][Full Text] [Related]
13. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis]. Potvin S; Stip E; Roy JY Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543 [TBL] [Abstract][Full Text] [Related]
14. Behavioral effects of intra-cranial self-stimulation in an animal model of attention-deficit/hyperactivity disorder (ADHD). Johansen EB; Sagvolden T Behav Brain Res; 2005 Jul; 162(1):32-46. PubMed ID: 15922065 [TBL] [Abstract][Full Text] [Related]
15. The search for the neurobiological basis of vulnerability to drug abuse: using microarrays to investigate the role of stress and individual differences. Kabbaj M; Evans S; Watson SJ; Akil H Neuropharmacology; 2004; 47 Suppl 1():111-22. PubMed ID: 15464130 [TBL] [Abstract][Full Text] [Related]
16. Reinforcement-related neurons in the primate basal forebrain respond to the learned significance of task events rather than to the hedonic attributes of reward. Wilson FA; Ma YY Brain Res Cogn Brain Res; 2004 Mar; 19(1):74-81. PubMed ID: 14972360 [TBL] [Abstract][Full Text] [Related]
17. Drug addiction. Part III. Pharmacotherapy of addiction. Vetulani J Pol J Pharmacol; 2001; 53(5):415-34. PubMed ID: 11990060 [TBL] [Abstract][Full Text] [Related]
18. Recent advances against substance abuse. Heading CE IDrugs; 2003 Jul; 6(7):681-7. PubMed ID: 12861473 [TBL] [Abstract][Full Text] [Related]
19. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia. Hudson CJ; Young LT; Li PP; Warsh JJ Synapse; 1993 Mar; 13(3):278-93. PubMed ID: 8497811 [TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy for alcohol-related disorders: what clinicians should know. Mariani JJ; Levin FR Harv Rev Psychiatry; 2004; 12(6):351-66. PubMed ID: 15764470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]